Published • loading... • Updated
Insilico Medicine and Eli Lilly Lead 13th ARDD Meeting at Harvard
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insilico Medicine and Eli Lilly Lead 13th ARDD Meeting at Harvard
Insilico Medicine and Eli Lilly To Lead ARDD 2026: A Landmark Event in Longevity Biotechnology This October, Boston will host the 13th Aging Research & Drug Discovery (ARDD) Meeting at Harvard University’s David Rubenstein Treehouse, marking a pivotal moment in longevity science. Organized by Insilico Medicine—the AI-driven biotech powerhouse now publicly traded in Hong Kong—and […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
